miR-125b-5p Suppresses Leukemia Cell Proliferation by Regulating MCL1

被引:0
|
作者
Zhou, Yan [1 ]
Zhu, Huan [1 ]
Han, Jinan [1 ]
Xu, Ying [1 ]
Wang, Dan [1 ]
Jin, Wen [1 ]
Zhu, Ruyuan [1 ]
Qiao, Lixing [1 ,2 ]
机构
[1] Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Dept Pediat, 87 Dingjiaqiao,Hunan Rd, Nanjing 210009, Jiangsu, Peoples R China
关键词
miR-125b-5p; MCL1; leukemia; proliferation; apoptosis; INHIBITS APOPTOSIS; EXPRESSION DATA;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Leukemia threatens children's health, and leukemia cell proliferation and apoptosis participate in the regulation of leukemia. The current study aims to probe into the miR-125b-5p biological function in regulating leukemia cell proliferation and apoptosis by myeloid cell leukemia 1 (MCL1). Quantitative real-time polymerase chain reaction was conducted to quantify miR-125b-5p expression in leukemia cells. Cell transfection, cell-counting assay 8, Western blot, and flow cytometry assays were applied to assess the miR-125b-5p function in leukemia. A dual-luciferase reporter gene assay was applied to investigate the mechanism. miR-125b-5p was lessened in leukemia cells, and the increased miR125b-5p repressed leukemia cell proliferation and boosted apoptosis. Further, miR-125b-5p could bound with the MCL1 3'-untranslated region and regulated its expression. Furthermore, the elevated expression of miR-125b-5p repressed leukemia cell proliferation and boosted apoptosis through downregulating MCL1. miR-125b-5p inhibited leukemia cell proliferation and boosted apoptosis through decreasing MCL1.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
  • [41] MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells
    Yuezhen Wang
    Jun Fang
    Feiying Gu
    Molecular Biotechnology, 2022, 64 : 1003 - 1012
  • [42] MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells
    Wang, Yuezhen
    Fang, Jun
    Gu, Feiying
    MOLECULAR BIOTECHNOLOGY, 2022, 64 (09) : 1003 - 1012
  • [43] miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1
    Tong, Zhiguo
    Liu, Nan
    Lin, Luoqiang
    Guo, Xinggang
    Yang, Dongdong
    Zhang, Qifan
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 75 : 129 - 136
  • [44] miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1
    Yang, Zifeng
    Zhang, Menglong
    Zhang, Jian
    Chu, Cunkun
    Hu, Bijuan
    Huang, Liyin
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [45] The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer's disease
    Yashooa, Raya Kh
    Nabi, Ari Q.
    HUMAN GENE, 2022, 34
  • [46] MiR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1
    Yang, Zifeng
    Zhang, Menglong
    Zhang, Jian
    Chu, Cunkun
    Hu, Bijuan
    Huang, Liyin
    Computational and Mathematical Methods in Medicine, 2022, 2022
  • [47] Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis
    Walasik, Izabela
    Klicka, Klaudia
    Grzywa, Tomasz M.
    Szymusik, Iwona
    Wielgos, Miroslaw
    Pietrzak, Bronislawa
    Ludwin, Artur
    Wlodarski, Pawel
    REPRODUCTIVE BIOLOGY, 2023, 23 (04)
  • [48] miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
    Dong Yang
    Ming Zhan
    Tao Chen
    Wei Chen
    Yunhe Zhang
    Sunwang Xu
    Jinchun Yan
    Qihong Huang
    Jian Wang
    Scientific Reports, 7
  • [49] Knockdown of LINC01224 Suppresses Colon Cancer Progression by Sponging miR-485-5p to Downregulate MCL1
    Yuan, Danping
    Zhu, Yanan
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7803 - 7812
  • [50] Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression
    Chen, Dong
    Lu, Xinxing
    Yang, Feiya
    Xing, Nianzeng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1415 - 1423